Abiopharma

News list

Director Desai Samir 🟢 acquired 756 shares (1 derivative) of Arhaus, Inc. (ARHS) Transaction Date: Mar 31, 2026 | Filing ID: 000003

Full text

News bot April 2, 2026, 8:18 p.m.
🔍 Desai Samir (Director)

Company: Arhaus, Inc. (ARHS)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 756
Detailed Transactions and Holdings:
- Acquired 756 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 756.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: The dividend equivalent rights accrued on unvested awards of Restricted Stock Units ("RSUs") outstanding on March 31, 2026 and vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock.
- REMARKS: Exhibit List Exhibit 24-Power of Attorney